EG Bio Introduces X-Caine and X-Pro Numbing Cream Series

Expanding ancillary products for professional aesthetic procedures

In February 2025, EG Bio Co., Ltd. expanded its professional product lineup with the introduction of the X-Caine and X-Pro numbing cream series, strengthening its ancillary offerings for aesthetic procedures.

The X-Caine and X-Pro series were introduced to support procedural comfort across a wide range of professional aesthetic treatments. By adding these products to its portfolio, EG Bio aims to provide distribution partners with complementary solutions that align with procedural workflows and market demand.

The launch of the numbing cream series reflects EG Bio’s strategy of building a well-rounded professional portfolio that goes beyond core injectable products. Ancillary solutions such as topical anesthetics play an important role in supporting treatment efficiency and overall procedural experience in professional settings.

With the introduction of X-Caine and X-Pro, EG Bio continues to enhance its portfolio with products designed to support distributors and professional partners through structured global distribution and long-term market development.

About EG Bio

EG Bio Co., Ltd. is a global B2B supplier and distribution partner specializing in professional aesthetic products. The company works with selected international brands and manufacturers to support structured global distribution, market development, and long-term partnerships across multiple regions.

EG Bio focuses on exclusive distribution models, portfolio expansion, and international market access, providing distributors and professional partners with reliable supply, clear positioning, and sustainable growth opportunities.